Sanford Markowitz, MD, Oncology, Cleveland, OH, UH Cleveland Medical Center

SanfordDMarkowitzMD

Oncology Cleveland, OH

Hematologic Oncology

Professor of Medicine, Case West Res University

Are you Dr. Markowitz?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 64 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Sanford Markowitz, MD is an oncologist in Cleveland, Ohio. He is currently licensed to practice medicine in Ohio and Illinois. He is affiliated with UH Cleveland Medical Center and is a Professor of Medicine at Case West Res University.

Education & Training

  • National Institutes of Health Clinical CenterFellowship, Medical Oncology, 1984 - 1987
  • University of ChicagoResidency, Internal Medicine, 1981 - 1984
  • Yale University School of MedicineClass of 1980

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 1987 - 2022
  • IL State Medical License
    IL State Medical License 1982 - 1993
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2003-2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Northern Ohio Live Castle Connolly, 2006-2007
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • Swallowable Device to Detect Barrett's Esophagus Receives FDA 510(K) Clearance
    Swallowable Device to Detect Barrett's Esophagus Receives FDA 510(K) ClearanceSeptember 5th, 2019
  • Seattle Startup Rodeo Therapeutics Raises More Cash for Regenerative Medicine Treatments
    Seattle Startup Rodeo Therapeutics Raises More Cash for Regenerative Medicine TreatmentsApril 2nd, 2019
  • Seattle Startup Rodeo Therapeutics Raises More Cash for Regenerative Medicine Treatments
    Seattle Startup Rodeo Therapeutics Raises More Cash for Regenerative Medicine TreatmentsApril 2nd, 2019
  • Join now to see all

Grant Support

  • Role Of Gene Enhancer Elements In Colon CancerNational Cancer Institute2012
  • Genetic Determinants Of Barrett'S Esophagus And Esophageal AdenocarcinomaNational Cancer Institute2011
  • Case GI SporeNational Cancer Institute2011
  • Identify And Validate Novel Epigenetic Molecular Markers For Colorectal NeoplasmNational Cancer Institute2010–2011
  • Identifying Inborn Genetic Susceptibility To Development Of Cancer MetastasisNational Cancer Institute2009–2011
  • New Familial Colon Cancer Gene Discovery VIA Combined Linkage And SNP AssociationNational Cancer Institute2008–2011
  • 15-Pgdh, A Novel In Vivo Suppressor Of Colon Neoplasia In Mouse And ManNational Cancer Institute2007–2011
  • Novel Molecular Markers Of Human Colon NeoplasiaNational Cancer Institute2006–2009
  • Obesity And Dietary Pathways Leading To Colon CancerNational Cancer Institute2005–2009
  • Obesity And Molecular Pathways Leading To Colon CancerNational Center For Research Resources2007
  • Program LeadersNational Cancer Institute2007
  • Susceptibility Genes For Human Colon NeoplasiaNational Cancer Institute1999–2005
  • Novel Mutator Phenotypes Important In Human Colon CancerNational Cancer Institute1996–2005
  • Gene Expression Of Colon Cancers That MetastasizeNational Cancer Institute2000–2004
  • Linkage Study Of Colorectal Polyps &Cancer: Familial CorrelationNational Center For Research Resources1999–2001
  • Tgf-B Receptor Gene Mutations Detected In Human CancerNational Cancer Institute1996–2000
  • Linkage Study Of Colorectal PolypsNational Center For Research Resources1997–1998
  • Linkage Study Of Colorectal Polyps: CancerNational Center For Research Resources1996
  • Transforming Functions Of Mutant Colon Cancer OncogenesNational Cancer Institute1992–1995
  • Novel Oncogene-Related Product Detected In Human ColonNational Cancer Institute1994
  • Novel Oncogene Related Product Detected In Human ColonNational Cancer Institute1991–1993
  • Novel Ocnogene Related Product Detected In Human ColonNational Cancer Institute1990

Professional Memberships

Hospital Affiliations